Normal levels of clusterin in cerebrospinal fluid in Alzheimer's disease, and no change after acute ischemic stroke
A-M. Lidström(Sahlgrenska University Hospital), Kaj Blennow(Sahlgrenska University Hospital), Camilla Hesse(Sahlgrenska University Hospital), Pam Fredman, Lars Rosengren(Sahlgrenska University Hospital), Pia Davidsson(AstraZeneca (South Korea))
Cited by 32
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k